Novo Nordisk sues Hims and Hers for patent infringement, causing a 16% drop in Hims' share price.
This episode covers Novo Nordisk's lawsuit against Hims and Hers over weight loss drug patents, amid the company's financial struggles and competition from Eli Lilly. It also discusses U.S. deposit insurance reform proposals following the Silicon Valley Bank collapse and touches on UK political tensions and a central bank leadership change in France.
